Response to mepolizumab treatment is sustained across 4-weekly dosing periods

Ian D. Pavord, Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Elisabeth H. Bel, Peter Howarth, Daniel J. Bratton, Frank C. Albers, Steven Yancey

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Response to mepolizumab treatment is sustained across 4-weekly dosing periods'. Together they form a unique fingerprint.

Medicine & Life Sciences